• Gastroesophageal reflux disease and proton pump inhibitors. PPIs have played a significant role in reducing refractory esophageal strictures resulting from GERD, as well as mitigating upper GI disease complications in general.
• Colorectal cancer screening. Over the past 20 years, colonoscopy has become the gold standard for colorectal cancer screening. Additionally, new technologies have joined the ranks of CRC screening options.
• Hepatitis C treatment. New treatments for HCV are effective, with significantly reduced side effects.
• Fecal microbiota transplantation. FMT has demonstrated efficacy in treating refractory Clostridium difficile infection.
More articles on gastroenterology:
3 GI physicians making headlines – June 19, 2015
Keeping up with quality reporting in GI: 2 gastroenterologists weigh in
ASGE names Dr. Douglas Faigel president: 5 key points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
